Stockscreener 앱 받기
23.85
3.17%
0.435
전일 마감가:
$23.41
열려 있는:
$23.74
하루 거래량:
52,373
Relative Volume:
0.31
시가총액:
$1.47B
수익:
-
순이익/손실:
$-46.13M
주가수익비율:
-29.36
EPS:
-0.8123
순현금흐름:
$-34.10M
1주 성능:
+22.38%
1개월 성능:
+23.06%
6개월 성능:
+72.55%
1년 성능:
+177.03%
1일 변동 폭
$23.59
$24.25
1주일 범위
$19.38
$24.25
52주 변동 폭
$6.595
$24.25
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
23.88 | 1.47B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
585.10 | 210.90B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
243.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
92.89 | 45.96B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
241.75 | 35.33B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.98 | 24.01B | 2.88B | 499.60M | 321.60M | 6.74 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace
Pulse Biosciences has a new CFO - Mass Device
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks
Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com
Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch
Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat
Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace
Revolutionary Thyroid Treatment Gets Spotlight: Pulse Bio's Game-Changing Tech Wows Medical Experts - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences reports successful AF treatment in study - MSN
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News
Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat
Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
Pulse Biosciences' Cardiac Catheter Shows 92% Success Rate in Atrial Fibrillation Study - StockTitan
Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Barclays PLC - MarketBeat
Pulse Biosciences (NASDAQ: PLSE) Updates Investor PresentationOn January 14, 2025, Pulse Biosciences, Inc., a Delaware corporation, announced that it has posted an updated investor presentation on its website. The revised investor presentation, known - Defense World
Pulse Biosciences Updates Investors on Cardiac Innovations - TipRanks
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium - BioSpace
Pulse Biosciences' Breakthrough nsPFA Cardiac Catheter to Headline AF Symposium 2025 - StockTitan
Jane Street Group LLC Has $233,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences announces CEO appointment - MSN
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer - BioSpace
Pulse Biosciences names Paul LaViolette as CEO By Investing.com - Investing.com Canada
Pulse Biosciences names Paul LaViolette as CEO - Investing.com India
Pulse Biosciences Appoints Co-Chairman Paul LaViolette as CEO - MarketWatch
Pulse Biosciences Names Boston Scientific Veteran LaViolette as CEO, Advances Cardiac Tech Pipeline - StockTitan
Pulse Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Trading 6.1% HigherShould You Buy? - MarketBeat
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Pulse Biosciences to Present Nano-PFA Technology at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Barclays PLC Buys 23,738 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Geode Capital Management LLC - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Upgraded to "Sell" at StockNews.com - MarketBeat
Franklin Resources Inc. Buys New Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Investment Report - Stock Traders Daily
State Street Corp Increases Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
State Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading Down 2.2%Time to Sell? - MarketBeat
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.70%
0.04%
자본화:
|
볼륨(24시간):